Summary
Introduction
It has long been known that the prescription, delivery and use of drugs in healthcare is a process prone to errors that may jeopardise patient safety [1] . Early studies focused on inpatient settings and showed that errors occurred in all steps of drug treatment. Errors during the ordering or administration process account for about 90% of preventable adverse events [2] [3] [4] . Computerised provider order entry (CPOE), defined as the process of entering medication orders electronically instead of on paper charts [e.g., 5] has been considered and promoted as an important tool to improve the quality and safety of drug prescription and thus reduce errors [6] . In 2009, about 15% of hospitals in the USA had put CPOE into service and numbers have rapidly increased since then; penetration is lower in European countries [7] . CPOE systems usually address four key points, namely: (a) the standardised prescription structure that leads to clear and complete orders; (b) the integration of all types of associated decision support; (c) the communication of information and continuity of care; and (d) the introduction of (entirely) paperless processes. CPOE platforms have proven to be very effective in preventing errors due to unclear or incomplete orders, and to dramatically decrease transcription errors [8] . However, many mistakes are triggered by a lack of knowledge [9] , and therefore, a CPOE platform should incorporate clinical decision support systems (CDSSs). Definitions of a CDSS vary; however, we consider a CDSS to be knowledge software designed to support clinical processes by linking patient data with medical-and/or drugspecific knowledge, and to provide advice for healthcare professionals while diagnosing, treating or monitoring patients [based on and modified from 10]. Such systems have been developed and put into service for various purposes, including disease diagnosis, prevention and management, and drug prescription [11] . The optimal way to design a CDSS and to integrate it into clinical workflow is still the subject of research. Moreover, in most cases, decision support is a combination of commercially and locally managed sources and systems. Thus, there is no broadly accepted standard to describe CDSS functionalities and content. This work aimed to assess the level of CPOE and particularly CDSS implementation in Swiss healthcare institutions by analysing voluntary responses to a survey sent out to all hospitals and clinics in Switzerland.
Methods

Development and structure of the survey
The survey was a pdf-based, four-page document organised into three sections. Section 1 was devoted to the definition of institutional characteristics, such as the number of beds, the type of hospital and the care setting. Section 2 addressed general aspects of CPOE, such as deployment dates, and CPOE and CDSS coverage within the institution. Section 3 focussed on different types of CDSS and their integration into the workflow (see appendix for the full questionnaire). The different types of CDSS were classified into four dimensions:
1. Current drug-related information such as monographs ("drug-related CDSS", e.g., dosage information). 2. Current drug with other active drugs for the patient ("comedication-related CDSS", e.g., drug-drug interactions). 3. Context-related CDSS ("setting-related CDSS", e.g., information on the hospital formulary). 4. Patient-specific CDSS ("patient-related CDSS", e.g., drug-pregnancy information).
Each type of CDSS was defined by a set of functionalities and specifications. For instance, the CDSS type "drug-duplicate alerts" (with reference to the "comedication-related CDSS" dimension) was subdivided into the functionalities "information on identical substances with comparable bioavailability", "information on substances from identical active drug class (ATC)", "therapeutic duplications, and "exceptions requiring duplicate treatment, e.g., bridging". For several types of CDSS, it was also possible to specify whether severity grades were available. In total, 53 different CDSS functionalities were assessed, allowing for the definition of 20 types of CDSS that were allocated across the four dimensions (table 1) . Detailed information on functionalities (i.e., specifications) was gathered for each type of CDSS in order to allow a precise description of them. Participants were also asked to specify how the CDSS was integrated into the workflow and the mode of user interaction. From the literature, we defined three categories related to how alerts were implemented [12, 13]:
1. Passive: all means of guiding prescribers with prefilled screens, such as default or pre-calculated values, mandatory fields, order sets, and frequent orders, etc. 2. Noninterruptive alerts: any type of interaction that can be perceived by the users during the process, but does not interrupt it and can be ignored without specific actions.
3. Interruptive alerts: any type of decision support that requires the user's immediate attention, interrupts the usual or current process, and cannot be ignored without specific actions.
The survey was tested with two hospitals and iteratively refined before being sent out.
Distribution of the survey
In February 2011, the survey was sent out as a pdf-questionnaire via e-mail to the medical directors or chief pharmacists of public hospitals (n = 120) and private clinics (n = 165) registered with the Swiss Hospitals Federation (H+). This federation includes most of the public and private inpatient organisations registered in Switzerland. The classification as public hospital or private clinic was derived from the Federal Statistical Office (OFS). Thereby, hospitals were defined according to the OFS as institutes for public health, which are financed by state and health insurance, compared to clinics which are private institutions. However, hospitals may have private treatments and clinics may have agreements with insurance companies to treat private patients [14] .
In the absence of feedback after the first invitation via email, non-responders were reminded a maximum of three times (one e-mail reminder after four weeks 
Data collection and analysis
The responses were manually transferred into an Excel sheet and the following parameters to describe institutions were included: (i.) the type of institution (hospital or clinic), (ii.) number of beds, and (iii.) region of Switzerland (i.e., French-speaking, German-speaking and Italianspeaking parts of Switzerland). If any of these details were missing, we looked up the institution's homepage for more information. If we received several responses from one institution, we telephoned to ask which response should be considered for the analysis. Descriptive statistics were reported as frequencies, mean and standard deviation.
Results
Participating hospitals and clinics
After four rounds of invitation and reminders, one-third of all hospitals and clinics responded to the survey (n = 92/ 285; 32.3%), with more hospitals (n = 52/120; 43.3%) than clinics (n = 40/162; 24.2%) answering. Forty-eight institutions (n = 48/92; 52.2%) responded to the first invitation, 23 (n = 23/92; 25.0%) to the first reminder, 5 (n = 5/92; 5.4%) to the second, and 16 (n = 16/92; 17.4%) to the third reminder. Among the responders, 37% were pharmacists, 14% physicians, 13% clinic managers, 8% medical directors, 4% directors of nursing and 3% quality managers. Nineteen (21%) responders did not state their occupation. Of all responders, 73 sent back a completed survey. A further 19 refused to participate, most often because the survey was not applicable or not of interest to the institution (n = 8), but also because it was not issued in German [15] . Of the 73 institutions participating in the survey, 42% had no CPOE in service (n = 31), 17.8% planned to introduce a CPOE (n = 13), and 39.7% did have a CPOE system in service in their institution (n = 29; two of those with partly implemented systems that were planned to be expanded). Implementation of CDSSs was less frequent: 14 institutions were actually using a CDSS (19.1%) and another 18 institutions were planning to (24.6%). Of these, 10 institutions detailed which CDSS they planned to introduce. Of the 41 institutions indicating that they had no CDSS in general, 7 nevertheless specified that some specific types of CDSSs were available (probably paper-based versions). Implementation rates for both CPOE and CDSSs were higher in hospitals than in clinics (51% vs 21% for CPOE and 24% vs 11% for CDSSs). Sixty-five of 73 institutions specified their number of beds, and bed numbers for the 8 remaining institutions were found via their internet sites. According to these responses, a total of 22,076 beds were included in this survey. According to the responses to the survey, in which the numbers of beds with implemented CPOE or a CDSS were sometimes specified as a range, between 8,013 to 9,278 beds were equipped with CPOE (33. 
Classification of CDSS functionalities
Of the 14 institutions with a CDSS in service, 12 institutions had introduced at least one module referring to the current drug (dimension 1), 12 institutions had modules related to the comedication (dimension 2), 13 had modules related to the setting (dimension 3) and 7 institutions had a CDSS relating to the patient (dimension 4). A total of 90 types of CDSS were implemented. The type of CDSS most often implemented was information on the formularies (n = 13) and information on drug-drug interactions (n = 11). Types of CDSS supporting prescriptions with regard to genotype were absent, and CDSS for drug-lab interactions, contraindications, specific age groups and corollary orders were rare (n = 1 institution each). Each institution had on average 6. implemented (25% quartile = 6, 75% quartile = 10.75). Hence, on average, only 15% of all possible CDSS functionalities were implemented. Of functionalities related to the prescription, to the comedication and the setting, one in four functionalities was implemented, but CDSS functionalities related to the patient were only rarely implemented (17 out of 148 functionalities, 11.5%) (table 3) . We obtained details about the implementation methodology for 85 of 90 types of CDSS, i.e., how the user had to interact with the software. Most CDSS types were implemented as passive or pre-structured information only (n = 56). Eight types were implemented as noninterruptive alerts only and eight types as interruptive alerts only.
Discussion
Via a country-wide survey, we assessed the self-reported grade of CPOE and CDSS implementation in Swiss hospitals and clinics. Results showed that 39.7% (n = 29) of responders were using a CPOE. Of those, 13 institutions had additional CDSS functionalities with another 3 institutions were planning to introduce a CDSS. However, of the 13 institutions planning to introduce CPOE, 12 also planned to introduce a CDSS (and 7 of them already used some CDSS functionalities, potentially available either on paper or via the intranet). Since CPOE systems have been shown to be very successful in preventing transcription errors, especially when linked to electronic medication administration records [16] . However, they have been less effective in reducing decision-based errors [17] , indicating that CPOE systems in this subset might be "second-generationtype" systems already are linked to CDSS systems at the time of introduction. However, this study also shows that the types of CDSS currently in service is rather basic, primarily providing information on monographs and driving prescribers with passive order-sets and protocols. Active decision-support, such as the extensive usage of patient-specific information or workflow-driven clinical pathways, that could be considered as third and fourth generation systems, were almost nonexistent, even though the specificity and hence positive predictive value of such alerts is considered higher [18] . In order to maximise the added-value of CDSSs, significant efforts need to be made. Switzerland's small, fractured market is surely one problem, as each of the 26 Cantons has legal autonomy over its own health regulation framework; this could discourage certain large companies from addressing this market. Moreover, it is clear that the required customisation of commercially available CDSSs requires significantly more manpower at each different institution [19] . This study has several limitations. After three rounds of reminders, the response rate was still only 32.3%. Nevertheless, this figure can be considered as appropriate when taking into account the length of the questionnaire. Previously published studies on cross-sectional surveys of healthcare practices reported response rates within a comparable range (28.8% for a survey on clinical pharmacist services [20] and 42% for a survey on self-reported acceptance and use of CDSSs [21] ). Nevertheless, the response rate could have been increased if the survey had been translated into the respective regional languages. Furthermore, association with national organisations could have been beneficial, either to promote the survey or to provide (financial) incentives for institutions to fill it out. The facultative aspect of the survey with about 70% of nonresponders has probably generated a selection bias, with an over-selection of responders using CPOE or a CDSS. Thus, the overall estimate of CPOE or CDSS in service in Switzerland would be most probably too high and may not reflect the actual implementation rate. However, this study was intended to evaluate the types of CDSS in CPOE rather than the overall implementation of CPOE. Moreover, the occupation and professions of the responders (e.g., quality manager, pharmacist, medical director) themselves might have influenced the survey's interpretation given their individual views on the functionalities and implementation of the system. The classification of CDSSs was piloted but not assessed in a large set of hospitals. Thus, some dimensions of the evaluation might not have been defined clearly enough. For example, we had to withdraw the question about being a teaching hospital because almost all hospitals indicated that they were a teaching hospital -whether or not they were linked to a university. Whilst the survey allowed responders to indicate that a CDSS was both commercially and locally developed (i.e., a mixed system), it was not possible to declare a "mixed" system for CPOE. However, some hospitals did report having both in-house and commercially developed CPOEs. This option should be included in future questionnaires. In a few cases, the questionnaire revealed contradicting results, e.g., reporting that no CDSS is available, but describing a CDSS in service. In such case, we assumed the "no CDSS" answer to be wrong and that a CDSS was available. Moreover, we did not assess any additional effects related to the introduction of CPOE or a CDSS, e.g., satisfaction, cost-effectiveness, potential benefit on prescription quality, or adverse outcomes. These were not within in the scope of this survey, but they are fields of research that require attention [22, 23] . Lastly, our survey reflects the situation in Switzerland and as such it is not readily transferable to other countries, since the introduction of CPOE and CDSS systems varies considerably between countries and is subject to nationally guided campaigns, incentives or constraints. Figures (large format)
Figure 1
Number of implementations of CPOE and CDSS over the years. Gray bars = implementation of clinical decision support (CDSS) systems; black bars = Implementation of computerised physician order entry (CPOE) systems.
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